These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28967199)

  • 1. Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
    Tron L; Lert F; Spire B; Dray-Spira R;
    HIV Med; 2017 Mar; 18(3):181-195. PubMed ID: 28967199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study.
    Grabar S; Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; Pradier C; Salmon D; Simon A; Pourcher V; Spano JP; Poizot-Martin I; Costagliola D
    HIV Med; 2019 Mar; 20(3):222-229. PubMed ID: 30693646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of and factors associated with depression among people living with HIV in France.
    Feuillet P; Lert F; Tron L; Aubriere C; Spire B; Dray-Spira R;
    HIV Med; 2017 Jul; 18(6):383-394. PubMed ID: 27625202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].
    Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP;
    HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Hou L; Murphy RL; Adewole IF; Simon MA
    BMC Health Serv Res; 2018 Nov; 18(1):885. PubMed ID: 30466437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
    Vigneshwaran E; Goruntla N; Bommireddy BR; Mantargi MJS; Mopuri B; Thammisetty DP; Veerabhadrappa KV; Bukke SPN
    BMC Cancer; 2023 Dec; 23(1):1216. PubMed ID: 38066496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial.
    Matignon M; Lelièvre JD; Lahiani A; Abbassi K; Desvaux D; Diallo A; Peraldi MN; Taburet AM; Saillard J; Delaugerre C; Costagliola D; Assoumou L; Grimbert P;
    HIV Med; 2019 Mar; 20(3):202-213. PubMed ID: 30688008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort.
    Makinson A; Tron L; Grabar S; Milleron B; Reynes J; Le Moing V; Morquin D; Lert F; Costagliola D; Guiguet M
    HIV Med; 2020 Mar; 21(3):180-188. PubMed ID: 31730270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
    Constantinou P; Dray-Spira R; Menvielle G
    BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined patterns of participation in cervical, breast, and colorectal cancer screenings and factors for non-participation in each screening among women in Japan.
    Ishii K; Tabuchi T; Iso H
    Prev Med; 2021 Sep; 150():106627. PubMed ID: 34019930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic inequalities to accessing vaccination against human papillomavirus in France: Results of the Health, Health Care and Insurance Survey, 2012.
    Guthmann JP; Pelat C; Célant N; Parent du Chatelet I; Duport N; Rochereau T; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2017 Apr; 65(2):109-117. PubMed ID: 28238476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
    Layet F; Murungi T; Ashaba N; Kigongo E; Opollo MS
    BMC Womens Health; 2024 Feb; 24(1):114. PubMed ID: 38347497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco smoking in HIV-infected versus general population in france: heterogeneity across the various groups of people living with HIV.
    Tron L; Lert F; Spire B; Dray-Spira R;
    PLoS One; 2014; 9(9):e107451. PubMed ID: 25202968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an Intervention in General Practice to Increase the Participation of Immigrants in Cervical Cancer Screening: A Cluster Randomized Clinical Trial.
    Møen KA; Kumar B; Igland J; Diaz E
    JAMA Netw Open; 2020 Apr; 3(4):e201903. PubMed ID: 32236530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Mycoplasma genitalium among HIV-infected women, Agence Nationale de Recherches sur le SIDA et les hépatites virales CO3 Aquitaine Cohort, France.
    Cazanave C; Lawson-Ayayi S; Hessamfar M; Neau D; Dupon M; Morlat P; Dabis F; de Barbeyrac B; Bébéar C; Pereyre S
    Sex Transm Dis; 2013 Aug; 40(8):653-4. PubMed ID: 23859915
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring Knowledge, Attitudes, and Practices Related to Breast and Cervical Cancers in Mongolia: A National Population-Based Survey.
    Yerramilli P; Dugee O; Enkhtuya P; Knaul FM; Demaio AR
    Oncologist; 2015 Nov; 20(11):1266-73. PubMed ID: 26417038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with uptake of breast and cervical cancer screening among Nepalese women: Evidence from Nepal Demographic and Health Survey 2022.
    Lamichhane B; Adhikari B; Poudel L; Pandey AR; Kakchhapati S; K C SP; Giri S; Dulal BP; Joshi D; Gautam G; Baral SC
    PLOS Glob Public Health; 2024; 4(3):e0002971. PubMed ID: 38466682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda.
    Wanyenze RK; Bwanika JB; Beyeza-Kashesya J; Mugerwa S; Arinaitwe J; Matovu JKB; Gwokyalya V; Kasozi D; Bukenya J; Makumbi F
    Glob Health Action; 2017; 10(1):1380361. PubMed ID: 29035163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do vulnerable groups access prevention services? Cervical cancer screening and HIV testing among homeless migrant women in the Paris metropolitan area.
    Poncet L; Panjo H; Ringa V; Andro A
    PLoS One; 2021; 16(8):e0255900. PubMed ID: 34388200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.